A value-based care agreement with Minnesota Oncology has resulted in big savings for members, Blue Cross and Blue Shield of Minnesota said Dec. 16.
The Latest
Prime Therapeutics will add Humira biosimilars in the same position in its formulary as the original drug, joining other pharmaceutical benefit managers in announcing similar policies.
New requirements for payers under CMS' Transparency in Coverage rule take effect Jan. 1.
Two states have youth uninsured rates above 10 percent (Texas and Wyoming), while two states have rates below 2 percent (Vermont and Massachusetts), according to 2021 U.S. Census data.
These are seven health plans expanding or launching products in new markets that Becker's has reported since Nov. 16:
Blue Cross and Blue Shield of Mississippi and the University of Mississippi Medical Center in Jackson have reached a contract agreement, ending one of the more intense payer-provider disputes over reimbursement rates in 2022.
Centene is expecting to see total revenues between $137.4 billion and $139.4 billion in 2023, down from the $142.7 billion to $144.7 billion it is projecting for this year.
An analyst likened the current payer merger and acquisition environment to an "arms race," during a Nov. 3 Cigna investor call.
Aspirus Health Plan has named Kyle Brua as president, effective Nov. 7, 2022.
Regence BlueShield and Seattle-based Virginia Mason Franciscan Health are partnering to launch an accountable health network Jan. 1 they say will provide "affordable, accessible and high-quality care to patients across the Puget Sound region."